Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Report by the ACNP Task Force on response and remission in major depressive disorder.

Rush AJ, Kraemer HC, Sackeim HA, Fava M, Trivedi MH, Frank E, Ninan PT, Thase ME, Gelenberg AJ, Kupfer DJ, Regier DA, Rosenbaum JF, Ray O, Schatzberg AF; ACNP Task Force.

Neuropsychopharmacology. 2006 Sep;31(9):1841-53. Epub 2006 Jun 21. Review.

2.

ECNP consensus meeting. Bipolar depression. Nice, March 2007.

Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen HU.

Eur Neuropsychopharmacol. 2008 Jul;18(7):535-49. doi: 10.1016/j.euroneuro.2008.03.003. Epub 2008 May 23. Review.

PMID:
18501566
3.

Prevalence and outcome of partial remission in depression.

Tranter R, O'Donovan C, Chandarana P, Kennedy S.

J Psychiatry Neurosci. 2002 Jul;27(4):241-7. Review.

4.

[Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].

Favré P.

Encephale. 2012 Feb;38(1):86-96. doi: 10.1016/j.encep.2011.11.003. Epub 2011 Dec 10. Review. French.

PMID:
22381728
5.

Outcomes in major depressive disorder: the evolving concept of remission and its implications for treatment.

Möller HJ.

World J Biol Psychiatry. 2008;9(2):102-14. doi: 10.1080/15622970801981606. Review.

PMID:
18428079
6.

Interventions for preventing relapse and recurrence of a depressive disorder in children and adolescents.

Cox GR, Fisher CA, De Silva S, Phelan M, Akinwale OP, Simmons MB, Hetrick SE.

Cochrane Database Syst Rev. 2012 Nov 14;11:CD007504. doi: 10.1002/14651858.CD007504.pub2. Review.

PMID:
23152246
7.

SNRIs in the management of acute major depressive disorder.

Zajecka JM, Albano D.

J Clin Psychiatry. 2004;65 Suppl 17:11-8. Review.

8.

[Depressions: current concepts].

Corruble E.

Encephale. 2010 Dec;36 Suppl 5:S104-7. doi: 10.1016/S0013-7006(10)70039-7. Review. French.

PMID:
21211627
9.

Continuation and maintenance therapy of early-onset major depressive disorder.

Emslie GJ, Mayes TL, Ruberu M.

Paediatr Drugs. 2005;7(4):203-17. Review.

PMID:
16117558
10.
11.
12.

The prevalence, clinical relevance, and public health significance of subthreshold depressions.

Judd LL, Schettler PJ, Akiskal HS.

Psychiatr Clin North Am. 2002 Dec;25(4):685-98. Review.

PMID:
12462855
13.

Consensus recommendations for improving adherence, self-management, and outcomes in patients with depression.

Trivedi MH, Lin EH, Katon WJ.

CNS Spectr. 2007 Aug;12(8 Suppl 13):1-27. Review.

PMID:
17986951
14.

The antidepressant agomelatine improves the quality of life of depressed patients: implications for remission.

Llorca PM.

J Psychopharmacol. 2010 Aug;24(2 Suppl):21-6. doi: 10.1177/1359786810372978. Review.

PMID:
20663805
15.

[Residual symptoms and recurrence in major depressive disorder].

Spadone C, Corruble E.

Encephale. 2010 Dec;36 Suppl 5:S108-11. doi: 10.1016/S0013-7006(10)70040-3. Review. French.

PMID:
21211628
16.

Depressive breakthrough.

Nierenberg AA, Alpert JE.

Psychiatr Clin North Am. 2000 Dec;23(4):731-42. Review.

PMID:
11147244
17.

The concept of recovery in major depression.

Fava GA, Ruini C, Belaise C.

Psychol Med. 2007 Mar;37(3):307-17. Review.

PMID:
17311684

Supplemental Content

Support Center